Xplametta 100mg (Oxaliplatin Vials) 100mg/50ml

Xplametta 100mg is an injectable chemotherapy medication containing oxaliplatin 100mg/50ml in vials, used for cancer treatment. This sterile solution is manufactured by Metta Lifesciences and stored at ambient temperature. It is prescribed for specific chemotherapy regimens under medical supervision.

Strength

100mg/50ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Metta Lifesciences Pvt. Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxaliplatin, the active ingredient in Xplametta 100mg, is commonly used as part of combination chemotherapy for colorectal cancer. It may also be used for other cancers as determined by a healthcare provider. This medication works by interfering with cancer cell growth. Patients often ask, 'what is oxaliplatin used for' in chemotherapy protocols.

Side Effects

Xplametta 100mg may cause temporary side effects such as nausea, fatigue, or numbness in hands and feet. Some patients experience sensitivity to cold temperatures during treatment. These effects vary and should be discussed with a healthcare professional. Most side effects are reversible after treatment completion.

Precautions & Warnings

Handle Xplametta 100mg with care as it is a cytotoxic medication. Use protective gloves and avoid skin contact. Store at ambient temperature away from direct light. Dispose of vials and unused solution according to local medical waste regulations. Always follow healthcare provider instructions for safe handling.

Avoid Interactions

Oxaliplatin may interact with other medications, including certain antibiotics, antifungals, and antivirals. Alcohol and herbal supplements may also affect treatment. Patients should inform their doctor about all medications and supplements being taken. Some interactions may increase side effects or reduce effectiveness.

References

Frequently Asked Questions

Xplametta 100mg is used in chemotherapy regimens, primarily for colorectal cancer treatment.

It is administered as an intravenous infusion by healthcare professionals in a clinical setting.

Common side effects include nausea, fatigue, and temporary numbness in extremities.

Xplametta 100mg is available through licensed pharmacies and medical suppliers with a prescription.

Store at ambient temperature, away from moisture and direct light.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.